KRO-11018

(2R)-2-amino-3,3-diphenylpropan-1-ol

171037-01-7
98% min.
scale-up (10-1,000 kg)
C15H17NO

KRO-10195

(2S)-2-amino-3,3-diphenylpropan-1-ol

162118-01-6
98% min.
scale-up (10-1,000 kg)
C15H17NO

KRO-10110

Solabegron HCl; Solabegron hydrochloride (USAN); 3''-((2-((2-(3-Chlorophenyl)-2-hydroxyethyl)amino)ethyl)amino)-(1,1''-biphenyl)-3-carboxylic acid; UNII-GU14FR8D4A

451470-34-1
98% min.
scale-up (10-1,000 kg)
C23H24Cl2N2O3

KRO-14169

4-(Dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide; 4-(Dimethylamino)-N-(7-(hydroxyamino)-7-oxoheptyl)benzamide; 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide

251456-60-7
98% min.
scale-up (10-1,000 kg)
C16H25N3O3

KRO-10200

5-amino-7-(3-(4-methoxyphenyl)propyl)-2-(2 furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine; HMS3269G07; Decynium 22

316173-57-6
98% min.
scale-up (10-1,000 kg)
C20H19N7O2

KRO-09744

N-hydroxy-4-({2-methyl-1H,3H,4H-pyrido[4,3-b]indol-5-yl}methyl)benzamide hydrochloride; N-Hydroxy-4-[(2-methyl-1,2,3,4-tetrahydro-5H-pyrido[4,3-b]indol-5 -yl)methyl]benzamide; TUBASTATIN A_HCL; [4-({2-methyl-1H,2H,3H,4H,5H-pyrido[4,3-b]indol-5-yl}methyl)phenyl]formamido 2,2,2-trifluoroacetate; TUBASTATIN A HYDROCHLORIDE; TUBASTSTINA HCL; Tubastatin A; TRIETHYLENETHIOPHOSPHORAMIDE,WHITE SOLID; TUBASTATIN A ((2-METHYL-3,4-DIHYDRO-1H-PYRIDO[4,3-B]-INDOL- 5(2H)-YL)METHYL)BENZAMIDE); Tubastatin A (trifluoroacetate salt); TUBASTANTIN A; Tubastatin A Trifluoroacetic Acid Salt

1239262-52-2
98% min.
scale-up (10-1,000 kg)
C22H22F3N3O4

KRO-14620

Quisinostat [USAN]; QUISINOSTAT; Quisinostat (USAN/INN); N-Hydroxy-2-(4-((((1-methyl-1H-indol-3-yl)methyl)amino)methyl)piperidin-1-yl)pyrimidine-5-carboxamide; UNII-9BJ85K1J8S

875320-29-9
98% min.
scale-up (10-1,000 kg)
C21H26N6O2

KRO-11679

(3Z)-5-[(2,6-dichlorophenyl)methylsulfonyl]-3-[[3,5-dimethyl-4-[(2R)-2-(pyrrolidin-1-ylmethyl)pyrrolidine-1-carbonyl]-1H-pyrrol-2-yl]methylidene]-1H-indol-2-one

477575-56-7
98% min.
scale-up (10-1,000 kg)
C32H34Cl2N4O4S

KRO-14512

Kinome_3532; Linsitinib; OSI-906 (Linsitinib); cis-3-[8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-1-yl]-1-methylcyclobutan-1-ol; cis-3-(8-amino-1-(2-phenyl-7-quinolinyl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol; OSI-906AA; cis-3-[8-amino-1-(2-phenyl-quinolin-7-yl)-imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutanol; OSI906

867160-71-2
98% min.
scale-up (10-1,000 kg)
C26H23N5O

KRO-07541

Linifanib; Linifanib (ABT-869); Kinome_532; ABT 869

796967-16-3
98% min.
scale-up (10-1,000 kg)
C21H18FN5O

KRO-16805

kro-16805

852808-04-9
98% min.
scale-up (10-1,000 kg)
C42H45ClN6O5S2

KRO-14731

kro-14731

1019779-04-4
98% min.
scale-up (10-1,000 kg)
C20H27Cl3F2N4O

KRO-15776

Deshydroxy LY-411575; N-[(1S)-2-[[(7S)-6,7-Dihydro-5-methyl-6-oxo-5H-dibenz[b,d]azepin-7-yl]amino]-1-methyl-2-oxoethyl]-3,5-difluorobenzeneacetamide; Dibenzazepine; DBZ

209984-56-5
98% min.
scale-up (10-1,000 kg)
C26H23F2N3O3

KRO-10202

2-(Ethyl((5-((6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl)amino)isothiazol-3-yl)methyl)amino)-2-methylpropan-1-ol; CS-1341; 2-[Ethyl[[5-[[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-3-isothiazolyl]methyl]amino]-2-methyl-1-propanol

1094069-99-4
98% min.
scale-up (10-1,000 kg)
C20H26N8OS

KRO-14619

3mxf; UNII-1MRH0IMX0W; 4flp

1268524-70-4
98% min.
scale-up (10-1,000 kg)
C23H25ClN4O2S

KRO-15599

Compound C; BML-275; 6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine; AMPK Inhibitor,Compound C

866405-64-3
98% min.
scale-up (10-1,000 kg)
C24H25N5O

KRO-11667

X6K; PI103

371935-74-9
98% min.
scale-up (10-1,000 kg)
C19H17ClN4O3

KRO-10204

Lopac-S-2064; 5-(4-Chlorophenyl)-1-(4-methoxyphenyl)-3-trifluoromethyl pyrazole; Ionomycin calcium salt; SC560

188817-13-2
98% min.
scale-up (10-1,000 kg)
C17H12ClF3N2O

KRO-49789

5H-DIBENZ(b,f)AZEPINE-5-CARBOXAMIDE,10,11-DIHYDRO; 10,11-Dihydro-5H-dibenzo[b,f]azepine-5-carboxamide; 10,11-Dihydro-5H-dibenz[b,f]azepine-5-carboxamide; 10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide; 10,11-Dihydrocarbamazepine; 10,11-Dihydro-5-carbamoyl-5H-dibenz<b,f>azepine; EINECS 222-649-0; 10,11-Dihydro-5H-dibenz(b,f)azepine-5-carboxamide; 10,11-Dihydrocarbamazepine,10,11-Dihydro-5H-dibenz[b,f]azepine-5-carboxamide; GP 26-301; 10,11-Dihydro-5-carbamoyl-5H-dibenz<b,f>azepin; 10,11-dihydro-5-carboxamido-5H-dibenz<b,f>azepine; 10,11-DIHYDROCARBAMAZEPINE

3564-73-6
98% min.
scale-up (10-1,000 kg)
C15H14N2O

KRO-05177

3-(2-(Imidazo[1,2-b]pyridazin-3-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide; Iclusig; PONATINIB; 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide; 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide

943319-70-8
98% min.
scale-up (10-1,000 kg)
C29H27F3N6O